Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Patent
1986-05-15
1990-07-31
Wax, Robert A.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
435219, 435267, 435268, 435269, 435272, C12N 964
Patent
active
049450557
ABSTRACT:
A substantially purified human chorionic gonadotropin releasing factor (hCG-RF) which is a glycoprotein with a molecular weight between about 50,000 and about 70,000. This hCG-RF is capable of stimulating release of human chorionic gonadotropin as well as prostaglandins, particularly from human term placental cultures. This hCG-RF is capable of degrading GnRH and is isolatable from human placenta, preferably term placenta. Such hCG-RF may be used to affect a state of pregnancy, particularly mammalian pregnancy. This effect upon pregnancy may comprise the induction of a normal labor.
REFERENCES:
patent: 4338305 (1982-07-01), Corbin
Seeburg et al., Nature, 311:666 (1984).
Lee et al., Acta Endocrinol., 96:394 (1981).
Tan et al., Biochem. Biophys. Res. Commun., 109:1061 (1982).
Siler-Khodr et al., Life Sci., 32:2742 (1983).
Siler-Khodr et al., Fertil. Steril., 41:448 (1984).
Gibbons et al., Am. J. Obstet. Gynecol., 121:127 (1975).
Siler-Khodr and Khodr, Am. J. Obstet. Gynecol., 130:216 (1978).
Siler-Khodr and Khodr, Fertil. Steril., 32:294 (1979).
Siler-Khodr et al., Am. J. Obstet. Gynecol., 150:376 (1984).
Khodr and Siler-Khodr, Fertil. Steril., 2:523 (1978).
Seppala et al., Clinical Endocrinol., 12:441 (1980).
Miyake et al., Obstet. Gynecol., 60:444 (1982).
Khodr and Siler-Khodr, Fertil. Steril., 30:301 (1978).
Siler-Khodr and Khodr, Biol. Reprod., 25:353 (1981).
Khodr and Siler-Khodr, Science, 207:315 (1980).
Siler-Khodr and Khodr, Fetal Endocrinology, Novy, Resko, Ed., Academic Press, New York, p. 183 (1981).
Siler-Khodr and Khodr, in Role of Peptides and Proteins in Control of Reproduction, Dhindsa McCann, Ed. Elsevier, North Holland, New York, p. 347 (1982).
Siler-Khodr, Clinics in Perinatol., 10:553 (1983)
Siler-Khodr, Sem. in Reproduct. Endocrinol., 1:321 (1983).
Siler-Khodr and Khodr, Endocrinology, 56:274 (Abstract #776) (1983).
Siler-Khodr et al., Scientific Program and Abstracts of the 31st Annual Meeting of the Society for Gynologic Investigation, San Francisco, California, Abstract No. 316:190 (1984).
Siler-Khodr et al., the 32nd Annual Meeting of the Society for Gyncologic Investigation, Phoenix, Arizona (1985).
Poisner et al., Federation Proceedings Abstract No. 1003, p. 326 (1986).
Gautron et al., Molec. Cell. Endocr., 24:1 (1981).
Seppala et al., Life Sciences, 25:1489 (1979).
Seppala et al., Life Sciences, 27:395 (1980).
Seppala and Wahlstrom, Int. J. Cancer, 26:267 (1980).
Eidne et al., Science, 229:989 (1985).
Dutlow and Miller, Biochem. Biophys. Res. Commun., 101:486 (1981).
Bhasin et al., Endocrinol., 112:1144 (1983).
Sokol et al., Biol. of Reprod., :370.
Harper M. J. K.
Khodr Gabriel S.
Kuehl Thomas J.
Siler-Khodr Theresa M.
Board of Regents University of Texas System
Wax Robert A.
LandOfFree
Human chorionic gonadotropin releasing factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human chorionic gonadotropin releasing factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human chorionic gonadotropin releasing factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1398609